Emerging evidence concerning systemic safety of anti-VEGF agents should ophthalmologists be concerned?

10.1016/j.ajo.2011.05.040American Journal of Ophthalmology1523329-331AJOP

Retinal arteriolar wall signs and early age-related macular degeneration: The Singapore Malay eye study

10.1016/j.ajo.2011.01.012American Journal of Ophthalmology1521108-113AJOP

Polypoidal choroidal vasculopathy and systemic lupus erythematosus

10.1177/0961203313519160Lupus233319-322LUPU

Polypoidal choroidal vasculopathy: outer retinal and choroidal changes and neovascularization development in the fellow eye

10.1167/iovs.18-24244Investigative Ophthalmology and Visual Science602590-59

Choroidal neovascularization in pathological myopia

10.1016/j.preteyeres.2012.04.001Progress in Retinal and Eye Research315495-525PRTR

High-density lipoprotein cholesterol in age-related ocular diseases

10.3390/biom10040645Biomolecules10464

Correlation of axial length and myopic macular degeneration to levels of molecular factors in the aqueous

10.1038/s41598-019-52156-yScientific Reports911570

A serum metabolomics study of patients with nAMD in response to anti-VEGF therapy

10.1038/s41598-020-58346-3Scientific Reports101134

Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study

10.1038/srep21090Scientific Reports62109

Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort

10.1001/archophthalmol.2011.376Archives of Ophthalmology1304480-486AROP